Quick take: Pharmaniaga, Duopharma climb on vaccine hopes


FILE PHOTO: Small bottles labelled with "Vaccine" stickers seen near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

KUALA LUMPUR: Shares of drug makers Pharmaniaga and Duopharma climbed in early Monday trade as hopes for a vaccine for the Covid-19 perked up after reports of human trials could start in Singapore as early as this week.

At 9.41am, the FBM KLCI was up 0.09 point to 1,589.70. Turnover was 2.06 billion shares valued at RM1.27bil. There were 381 gainers, 340 losers and 350 counters unchanged.

Pharmaniaga rose 10 sen to RM3.73 and Duopharma eight sen to RM2.70.

Pharmaniaga and Duopharma were picked by the government to pack the Covid-19 vaccine when publicly made available.

Singapore Straits Times reported on Sunday the trial will involve 108 healthy volunteers of various ages in Singapore who will be injected with the vaccine developed by Duke-NUS Medical School and United States pharmaceutical company Arcturus Therapeutics.

Called Lunar-Cov19, the vaccine is one of 25 vaccine candidates worldwide that either have been tested on humans, or have received approval to do so. Some 141 others are still at a pre-clinical phase, the newspaper reported on its website.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

   

Did you find this article insightful?

Yes
No

60% readers found this article insightful

Next In Business News

Kenanga IB profit up tenfold as brokerage, trading income soar
Palm oil’s stunning rally is set to boost supermarket prices
Alliance Bank posts lower 2Q net profit of RM103.94m on higher reserves
Pandemic and travel curbs hit Datasonic Q2 earnings�
Higher net profit for Hong Leong Bank
KNM bags RM93.6mil job in Berlin
Axiata records 3Q earnings recovery
Maybank records lower net profit of RM1.95b in 3Q
KLCI stays afloat of 1,600, bank earnings in focus
October exports up 0.2% to RM91.1b, exceed forecast

Stories You'll Enjoy